financetom
Business
financetom
/
Business
/
Ari Emanuel's MARI buys theater operator ATG Entertainment
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ari Emanuel's MARI buys theater operator ATG Entertainment
Aug 11, 2026 8:10 AM

Aug 11 (Reuters) - MARI Group said on Tuesday it has signed

a deal to acquire British West End theater operator ATG

Entertainment, in the latest acquisition by the global live

events company founded by Hollywood power broker Ari Emanuel

last year.

Here are more details:

* Financial terms of MARI's acquisition of the theater

operator from Providence Equity Partners were not disclosed, but

the Financial Timessaid the deal was valued at about £4.5

billion ($6.07 billion).

* ATG Entertainment owns and operates 70 venues across the

UK, the U.S., Germany and Spain, entertaining more than 18

million audience members each year.

* ATG's portfolio includes Broadway venues including the

Walter Kerr Theater and the Lyric, and features shows like

"Harry Potter and the Cursed Child" and "The Lion King".

* Reuters had reported in May that ATG Entertainment is in

the early stages of being prepared for a possible sale.

* "MARI intends to act as a long-term custodian of ATG's

theaters, investing in their preservation and modernization

alongside an improved audience experience and support for new

productions, to the benefit of theatergoers and producers

alike," the company said in a statement.

* Since launching MARI in October, Emanuel has acquired

assets such as digital ticketing platform TodayTix, the Miami

Open, Frieze art fairs and Barrett-Jackson auto auctions.

* Emanuel is also the CEO of Ultimate Fighting Championship

and World Wrestling Entertainment owner TKO Group ( TKO ).

($1 = 0.7409 pounds)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
International Petroleum Released Results of Latest Normal Course Issuer Bid
International Petroleum Released Results of Latest Normal Course Issuer Bid
Aug 18, 2025
07:47 AM EDT, 08/18/2025 (MT Newswires) -- International Petroleum ( IPCFF ) earlier on Monday announced that it repurchased a total of 144,952 common shares during the period of August 11 to 15, 2025 under its normal course issuer bid, share repurchase program (NCIB). During the period, IPC repurchased a total of 88,052 IPC common shares on Nasdaq Stockholm. During...
FibroGen Says China Unit Sale to AstraZeneca Receives Regulatory Approval
FibroGen Says China Unit Sale to AstraZeneca Receives Regulatory Approval
Aug 18, 2025
07:44 AM EDT, 08/18/2025 (MT Newswires) -- FibroGen ( FGEN ) said Monday the China State Administration for Market Regulation has approved the sale of its subsidiary in China to AstraZeneca ( AZN ) unit AstraZeneca Treasury. FibroGen ( FGEN ) said the transaction remains on track to close in Q3, pending other contractual conditions and deliverables. FibroGen ( FGEN...
Trident Digital Tech Acquires 30% Stake in Tongxin for $3 Million
Trident Digital Tech Acquires 30% Stake in Tongxin for $3 Million
Aug 18, 2025
07:39 AM EDT, 08/18/2025 (MT Newswires) -- Trident Digital Tech ( TDTH ) said Monday that it has agreed to acquire a 30% equity stake in Tongxin Innovation for approximately $3 million. Tongxin Innovation operates the ToMe Web 3.0 e-commerce platform on Telegram. The company said the deal, which values Tongxin at approximately $10 million, will be completed by issuing...
Labcorp Holdings Launches FDA-Cleared Blood Test Lumipulse to Help Diagnose Alzheimer's Disease
Labcorp Holdings Launches FDA-Cleared Blood Test Lumipulse to Help Diagnose Alzheimer's Disease
Aug 18, 2025
07:39 AM EDT, 08/18/2025 (MT Newswires) -- Labcorp Holdings ( LH ) said Monday that Lumipulse, the first blood test cleared by the US Food and Drug Administration to help diagnose Alzheimer's disease, is now available nationwide. The test offers results that are comparable to existing methods, but is less invasive and more affordable and accessible, the company said. Lumipulse...
Copyright 2023-2026 - www.financetom.com All Rights Reserved